AAAAAA

   
Results: 1-10 |
Results: 10
Myth, menace or medical blessing? The clinical potential and the problems of genetic vaccines
Authors: Leitner, WW
Citation: Ww. Leitner, Myth, menace or medical blessing? The clinical potential and the problems of genetic vaccines, EMBO REP, 2(3), 2001, pp. 168-170
Nucleic acid for the treatment of cancer: Genetic vaccines and DNA adjuvants
Authors: Leitner, WW Hammerl, P Thalhamer, J
Citation: Ww. Leitner et al., Nucleic acid for the treatment of cancer: Genetic vaccines and DNA adjuvants, CUR PHARM D, 7(16), 2001, pp. 1641-1667
Removal of the circumsporozoite protein (CSP) glycosylphosphatidylinositolsignal sequence from a CSP DNA vaccine enhances induction of CSP-specific Th2 type immune responses and improves protection against malaria infection
Authors: Scheiblhofer, S Chen, DF Weiss, R Khan, F Mostbock, S Fegeding, K Leitner, WW Thalhamer, J Lyon, JA
Citation: S. Scheiblhofer et al., Removal of the circumsporozoite protein (CSP) glycosylphosphatidylinositolsignal sequence from a CSP DNA vaccine enhances induction of CSP-specific Th2 type immune responses and improves protection against malaria infection, EUR J IMMUN, 31(3), 2001, pp. 692-698
Mining the melanosome for tumor vaccine targets: P. polypeptide is a noveltumor-associated
Authors: Touloukian, CE Leitner, WW Robbins, PF Rosenberg, SA Restifo, NP
Citation: Ce. Touloukian et al., Mining the melanosome for tumor vaccine targets: P. polypeptide is a noveltumor-associated, CANCER RES, 61(22), 2001, pp. 8100-8104
The promise of nucleic acid vaccines
Authors: Restifo, NP Ying, H Hwang, L Leitner, WW
Citation: Np. Restifo et al., The promise of nucleic acid vaccines, GENE THER, 7(2), 2000, pp. 89-92
Identification of a MHC class II-restricted human gp100 epitope using DR4-IE transgenic mice
Authors: Touloukian, CE Leitner, WW Topalian, SL Li, YF Robbins, PF Rosenberg, SA Restifo, NP
Citation: Ce. Touloukian et al., Identification of a MHC class II-restricted human gp100 epitope using DR4-IE transgenic mice, J IMMUNOL, 164(7), 2000, pp. 3535-3542
Genetic vaccination against malaria infection by intradermal and epidermalinjections of a plasmid containing the gene encoding the Plasmodium berghei circumsporozoite protein
Authors: Weiss, R Leitner, WW Scheiblhofer, S Chen, DF Bernhaupt, A Mostbock, S Thalhamer, J Lyon, JA
Citation: R. Weiss et al., Genetic vaccination against malaria infection by intradermal and epidermalinjections of a plasmid containing the gene encoding the Plasmodium berghei circumsporozoite protein, INFEC IMMUN, 68(10), 2000, pp. 5914-5919
Enhancement of tumor-specific immune response with plasmid DNA replicon vectors
Authors: Leitner, WW Ying, H Driver, DA Dubensky, TW Restifo, NP
Citation: Ww. Leitner et al., Enhancement of tumor-specific immune response with plasmid DNA replicon vectors, CANCER RES, 60(1), 2000, pp. 51-55
Cancer therapy using a self-replicating RNA vaccine
Authors: Ying, H Zaks, TZ Wang, RF Irvine, KR Kammula, US Marincola, FM Leitner, WW Restifo, NP
Citation: H. Ying et al., Cancer therapy using a self-replicating RNA vaccine, NAT MED, 5(7), 1999, pp. 823-827
DNA and RNA-based vaccines: principles, progress and prospects
Authors: Leitner, WW Ying, H Restifo, NP
Citation: Ww. Leitner et al., DNA and RNA-based vaccines: principles, progress and prospects, VACCINE, 18(9-10), 1999, pp. 765-777
Risultati: 1-10 |